Lovesac (NASDAQ:LOVE) Issues FY 2027 Earnings Guidance

Lovesac (NASDAQ:LOVE) updated its FY 2027 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.340-0.810 for the period, compared to the consensus estimate of 1.250. The company issued revenue guidance of $700.0 million-$740.0 million, compared to the consensus revenue estimate of $719.4 million. Lovesac also updated its Q2 2027 guidance to 0.200-0.480 EPS.

Analyst Ratings Changes

Several research firms have commented on LOVE. Weiss Ratings reissued a “sell (d)” rating on shares of Lovesac in a research note on Friday, March 27th. Wall Street Zen raised shares of Lovesac from a “sell” rating to a “hold” rating in a research note on Saturday, April 4th. Canaccord Genuity Group set a $22.00 price target on shares of Lovesac in a research note on Thursday. Finally, Roth Mkm reissued a “buy” rating on shares of Lovesac in a research note on Friday, March 27th. Four analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Lovesac currently has an average rating of “Moderate Buy” and a consensus target price of $22.00.

Lovesac Stock Down 1.1%

Shares of NASDAQ LOVE opened at $16.30 on Friday. Lovesac has a 52 week low of $10.33 and a 52 week high of $20.88. The firm’s fifty day moving average is $15.88 and its 200 day moving average is $14.38. The company has a market cap of $240.91 million, a price-to-earnings ratio of 56.21, a PEG ratio of 0.80 and a beta of 2.02.

Lovesac (NASDAQ:LOVE) last issued its earnings results on Thursday, June 11th. The company reported ($0.76) EPS for the quarter, topping the consensus estimate of ($1.03) by $0.27. Lovesac had a net margin of 0.58% and a return on equity of 2.02%. The company had revenue of $138.20 million for the quarter, compared to the consensus estimate of $136.66 million. During the same period in the previous year, the firm earned ($0.73) earnings per share. The firm’s revenue for the quarter was down .1% on a year-over-year basis. Lovesac has set its Q2 2027 guidance at 0.200-0.480 EPS and its FY 2027 guidance at 0.340-0.810 EPS. Equities research analysts anticipate that Lovesac will post 0.59 earnings per share for the current year.

Insider Activity at Lovesac

In other news, CEO Shawn David Nelson bought 1,477 shares of the firm’s stock in a transaction that occurred on Thursday, April 16th. The shares were bought at an average cost of $16.95 per share, with a total value of $25,035.15. Following the completion of the purchase, the chief executive officer directly owned 202,681 shares in the company, valued at $3,435,442.95. This represents a 0.73% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. 7.79% of the stock is currently owned by insiders.

Key Lovesac News

Here are the key news stories impacting Lovesac this week:

• Positive Sentiment: Lovesac beat quarterly expectations, posting a smaller-than-expected loss of $0.76 per share versus the $1.03 loss analysts expected, while revenue of $138.2 million also topped estimates. The Lovesac Company earnings report
• Positive Sentiment: The company said it is seeing market-share gains from its “Designed for Life” ecosystem and highlighted record product launches ahead, which supports the long-term growth narrative. Lovesac Q1 fiscal 2027 financial results
• Neutral Sentiment: Management also discussed navigating ongoing industry headwinds, and the earnings call/transcript focused on strategic execution rather than a major near-term catalyst. Lovesac Q1 2027 earnings call transcript
• Negative Sentiment: The bigger pressure point was guidance: Lovesac’s FY2027 EPS outlook of $0.34 to $0.81 came in well below Wall Street’s expectations, and revenue guidance also landed below consensus. Lovesac outlook update
• Negative Sentiment: Media coverage emphasized that the company tempered its outlook as losses widened, reinforcing concerns that demand remains challenged despite the earnings beat. Wall Street Journal coverage of Lovesac outlook

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Invesco Ltd. boosted its holdings in Lovesac by 32.3% in the fourth quarter. Invesco Ltd. now owns 73,880 shares of the company’s stock valued at $1,090,000 after acquiring an additional 18,027 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in Lovesac by 139.4% in the fourth quarter. Corient Private Wealth LLC now owns 278,863 shares of the company’s stock valued at $4,113,000 after acquiring an additional 162,356 shares in the last quarter. Empowered Funds LLC boosted its holdings in Lovesac by 10.8% in the fourth quarter. Empowered Funds LLC now owns 76,547 shares of the company’s stock valued at $1,129,000 after acquiring an additional 7,483 shares in the last quarter. XTX Topco Ltd bought a new stake in Lovesac in the fourth quarter valued at $149,000. Finally, Millennium Management LLC boosted its holdings in Lovesac by 378.9% in the fourth quarter. Millennium Management LLC now owns 327,477 shares of the company’s stock valued at $4,830,000 after acquiring an additional 259,097 shares in the last quarter. 91.32% of the stock is owned by hedge funds and other institutional investors.

About Lovesac

Lovesac, trading on NASDAQ under the symbol LOVE, is an American furniture company known for its modular seating systems and distinctive foam-filled “Sacs.” Founded in 1995 by Shawn Nelson, the company has built a reputation for innovative design that emphasizes comfort, durability and adaptability. Its core offerings include Sactionals—customizable sectional sofas assembled from individual “Sactional” cubes—and the original Lovesac Sacs, large fabric-covered bean bag chairs available in a variety of sizes and materials.

In addition to seating solutions, Lovesac has expanded into home entertainment products with the introduction of the Stage, a modular soundbar system designed to integrate seamlessly with Sactionals.